Details of the Drug

General Information of Drug (ID: DMYIIDP)

Drug Name
MC-1101
Indication
Disease Entry ICD 11 Status REF
Diabetic retinopathy 9B71.0 Phase 2/3 [1]
Cross-matching ID
PubChem CID
9351
TTD ID
D01WLE
Drug ADMET Endpoint Profile (DAE)NEW Click to Jump to the Detailed DAE Information of This Drug
Combinatorial Drugs (CBD) Click to Jump to the Detailed CBD Information of This Drug

References

1 ClinicalTrials.gov (NCT02127463) Phase II/III Study of the Efficacy and Safety of MacuCLEAR MC-1101 in Treating DryAge-Related Macular Degeneration. U.S. National Institutes of Health.